Potentiation of naphthoxyloside cytotoxicity on human tumor cells by difluoromethylornithine and spermine-NONOate

Cancer Letters

Volumn 273, Issue 1, 2009, Pages 148-154

  Cheng, Fang ^a   Johnsson, Richard ^b   Nilsson, Jakob ^b   Fransson, Lars Åke ^a   Ellervik, Ulf ^b   Mani, Katrin ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Difluoromethylornithine; Glypican; Heparan sulfate; Heparan sulfate proteoglycans; Naphthol; Nitric oxide; Polyamine; Spermine; Xyloside

Indexed keywords

2 (6 HYDROXYNAPHTHYL) O BETA D XYLOPYRANOSIDE; EFLORNITHINE; HEPARAN SULFATE; NAPHTHALENE; NAPHTHOXYLOSIDE; NITRIC OXIDE; POLYAMINE; PYRANOSIDE; SPERMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NONHUMAN; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; RAT; TUMOR CELL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOHYDRATE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; EFLORNITHINE; GLYCOSIDES; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NAPHTHOLS; POLYAMINES; SPERMINE;

EID: 56349085463     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.07.036     Document Type: Article

References (18)

1. Sasisekharan R., Shriver Z., Venkataraman G., and Narayanasami U. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer 2 (2002) 521-528
2. Fransson L.A., and Mani K. Novel aspects of vitamin C: how important is glypican-1 recycling?. Trends Mol. Med. 13 (2007) 143-149
3. Fjeldstad K., and Kolset S.O. Decreasing the metastatic potential in cancers - targeting the heparan sulfate proteoglycans. Curr. Drug Targets 6 (2005) 665-682
4. Stringer S.E. The role of heparan sulphate proteoglycans in angiogenesis. Biochem. Soc. Trans. 34 (2006) 451-453
5. Bishop J.R., Schuksz M., and Esko J.D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446 (2007) 1030-1037
6. Esko J.D., and Lindahl U. Molecular diversity of heparan sulfate. J. Clin. Invest. 108 (2001) 169-173
7. Fritz T.A., Lugemwa F.N., Sarkar A.K., and Esko J.D. Biosynthesis of heparan sulfate on β-d-xylosides depends on aglycone structure. J. Biol. Chem. 269 (1994) 300-307
8. Mani K., Havsmark B., Persson S., Kaneda Y., Yamamoto H., Sakurai K., Ashikari S., Habuchi H., Suzuki S., Kimata K., Malmström A., Westergren-Thorsson G., and Fransson L.A. Heparan/chondroitin/dermatan sulfate primer 2-(6-hydroxynaphthyl)-O-β-d-xylopyranoside preferentially inhibits growth of transformed cells. Cancer Res. 58 (1998) 1099-1104
9. Gerner E.W., and Meyskens Jr. F.L. Polyamines and cancer: old molecules, new understanding. Nat. Rev. Cancer 4 (2004) 781-792
10. Belting M., Persson S., and Fransson L.A. Proteoglycan involvement in polyamine uptake. Biochem. J. 338 (1999) 317-323
11. Ding K., Sandgren S., Mani K., Belting M., and Fransson L.A. Modulations of glypican-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase, and nitric oxide/nitrite cleavage sites. J. Biol. Chem. 276 (2001) 46779-46791
12. Belting M., Mani K., Jonsson M., Cheng F., Sandgren S., Jonsson S., Ding K., Delcros J.G., and Fransson L.A. Glypican-1 is a vehicle for polyamine uptake in mammalian cells: a pivital role for nitrosothiol-derived nitric oxide. J. Biol. Chem. 278 (2003) 47181-47189
13. Belting M., Borsig L., Fuster M.M., Brown J.R., Persson L., Fransson L.A., and Esko J.D. Tumor attenuation by combined heparan sulfate and polyamine depletion. Proc. Natl. Acad. Sci. USA 99 (2002) 371-376
14. Jacobsson M., Ellervik U., Belting M., and Mani K. Selective antiproliferative activity of hydroxynaphthyl-β-d-xylosides. J. Med. Chem. 49 (2006) 1932-1938
15. Johnsson R., Mani K., and Ellervik U. Synthesis and biology of bis-xylosylated dihydroxynaphthalenes. Bioorg. Med. Chem. 15 (2007) 2868-2877
16. Mani K., Belting M., Ellervik U., Falk N., Svensson G., Sandgren S., Cheng F., and Fransson L.A. Tumor attenuation by 2(6-hydroxynaphthyl)-β-d-xylopyranoside requires priming of heparan sulfate and nuclear targeting of the products. Glycobiology 14 (2004) 387-397
17. Johnsson R., Mani K., and Ellervik U. Evaluation of fluorescently labeled xylopyranosides as probes for proteoglycan biosynthesis. Bioorg. Med. Chem. Lett. 17 (2007) 2338-2341
18. Fuster M.M., Brown J.R., Wang L., and Esko J.D. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res. 63 (2003) 2775-2781